Zobrazeno 1 - 10
of 233
pro vyhledávání: '"Trefor Morgan"'
Autor:
Lindon M H Wing, Graham J. Macdonald, John Marley, Trefor Morgan, Enayet K. Chowdhury, John J McNeil, Jenny Doust, C. I. Johnston, Malcolm J. West, Philip Ryan, Garry L. Jennings, Monique Breslin, Lawrence J. Beilin, Mark Nelson, Christopher M. Reid, Chau L. B. Ho
Publikováno v:
Journal of Clinical Lipidology. 13:148-155
Background There is currently insufficient evidence to support the use of lipid-lowering drug treatment (LLT) for primary prevention of cardiovascular disease (CVD) in the elderly. Objectives We examined the relationship of early initiation of LLT wi
Autor:
Peter M. Nilsson, Arun Jose, George S. Stergiou, Trefor Morgan, Aletta E. Schutte, Dylan Burger, Rafael R Castillo, Sadayoshi Ito, Claudio Borghi, Neil R Poulter, Thomas Unger, Richard D Wainford, Thomas Beaney, Markus P. Schlaich, Ruan Kruger, Albertino Damasceno
Publikováno v:
European Heart Journal Supplements : Journal of the European Society of Cardiology
European Heart Journal Supplements, 22(H), H1-H4. Oxford University Press
H4
H1
European Heart Journal Supplements, 22(H), H1-H4. Oxford University Press
H4
H1
In May 2017, the International Society of Hypertension (ISH) introduced the first in a series of annual blood pressure (BP) screening programmes with the simple aim of raising awareness of the importance of raised BP as the single biggest contributor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b58e871c1d2df339cdb5928dcbaed61
https://hdl.handle.net/11585/800556
https://hdl.handle.net/11585/800556
Autor:
J. Gambrill, S. Moore, J. Newbury, Geoffrey A. Donnan, Marilyn McMurchie, F. Boyle, David A Gleave, A. Bruce, Christopher A Silagy, B. McDermott, P. Fletcher, Mark Brown, Stephen MacMahon, Colin I. Johnston, Stephen B. Harrap, Leon Piterman, Jonathan R. Thompson, Paul Glasziou, Michael P. Feneley, P. Webb, Kristyn Willson, J. A. Whitworth, C. Bear, P. Beckinsale, J. Primrose, C. Dibben, John R. Moss, Enayet K. Chowdhury, Lindon M H Wing, F. De Looze, Garry L. Jennings, Fred DeLooze, Je Marley, Philip Joseph, Trefor Morgan, Jan E. Dickinson, V. Cope, Mark Nelson, Elizabeth M Dewar, Philip Ryan, Lawrence J. Beilin, G. Fraser, Christopher M. Reid
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Information is scarce regarding effects of antihypertensive medication on blood pressure variability ( BPV ) and associated clinical outcomes. We examined whether antihypertensive treatment changes BPV over time and whether such change (de
Autor:
Trefor Morgan
Publikováno v:
Hypertension News.
Publikováno v:
The Chinese Journal of Physiology. 57:335-342
The recent discovery of the new components of the renin-angiotensin system (RAS) suggests the importance of the maintenance of cardiovascular structure and functions. To assess the role of the angiotensin-converting enzyme 2 (ACE2)-Mas receptor axis
Publikováno v:
Journal of Hypertension. 36:e26-e27
Autor:
Trefor Morgan
Publikováno v:
Journal of Hypertension
Objective: Studies suggest that bedtime dosing of an angiotensin-converting enzyme (ACE)-inhibitor or angiotensin receptor blocker shows a more sustained and consistent 24-h antihypertensive profile, including greater night-time blood pressure (BP) r
Publikováno v:
Journal of Hypertension. 36:e26
Autor:
Trefor Morgan
Publikováno v:
Expert Review of Cardiovascular Therapy. 8:803-809
Blood pressure (BP) varies throughout the day owing to interactions between the sympathetic nervous and the renin-angiotensin systems. When awake BP is controlled by sympathetic nervous system activity but during sleep the renin-angiotensin system be
Autor:
Krisela Steyn, Trefor Morgan, George A. Mensah, Henry R. Black, A Coenen, Giuseppe Mancia, Martha N. Hill, Thomas D. Giles, Sverre E. Kjeldsen, George L. Bakris, P Mulrow, Thomas G. Pickering, A Loh, S. De Geest, Luis M. Ruilope, Ernesto L. Schiffrin
Publikováno v:
Journal of Human Hypertension. 22:63-70
The prevalence of hypertension continues to rise across the world, and most patients who receive medical intervention are not adequately treated to goal. A Working Group including representatives of nine international health-care organizations was co